< Back to search
Filter
1
Active & Responsive

A 2-part Phase 1/2 Open-label Trial on ODM-212

for
Mesothelioma, Pancreatic Cancer,
Location: Fairfax VA, Irving TX
Sponsor: Orion Corporation, Orion Pharma

Sex: All

Age: 18+

Code: NCT07563738

Phase1, Phase2, Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Philadelphia PA, Fairfax VA, Orlando FL,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase1, Phase2, Recruiting
Active & Responsive

Pancreas Registry and High Risk Registry

for
Pancreas Cancer, Pancreatitis, Chronic Pancreatitis,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT02775461

Recruiting
Active & Responsive

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Hartford CT, New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC

Sex: All

Age: 18 - 70+

Code: NCT03556228

Phase1, Phase2, Recruiting
Active & Responsive

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

for
Locally Advanced Pancreatic Cancer
Location: Manhasset NY, Greenville NC, Washington D.C. DC,
Sponsor: RenovoRx

Sex: All

Age: 18+

Code: NCT03257033

Phase3, Recruiting

Interested in new pancreatic cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT05723107

Phase1, Recruiting
Active & Responsive

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

for
Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06648434

Phase1, Recruiting
Active & Responsive

Pancreas Ultrasound Imaging in type1 Diabetes

for
Type1diabetes, Insulitis, Pancreas Inflamed
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 65

Code: NCT05482321

Recruiting
Active & Responsive

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

for
Shwachman-Diamond Syndrome, SDS, IBMF, Congenital Neutropenia,
Location: Woburn MA
Sponsor: Shwachman-Diamond Syndrome Alliance Inc

Sex: All

Age: 0+

Code: NCT06999954

Recruiting
Active & Responsive

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Waterford CT, New Haven CT, Stony Brook NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04671667

Phase2, Recruiting
Active & Responsive

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

for
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Boston MA, New York NY, Fairfax VA, Durham NC,
Sponsor: Alterome Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06835569

Phase1, Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Providence RI, New York NY, Newark NJ,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & ResponsiveNew

Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

for
Resectable Pancreatic Ductal Adenocarcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07645651

Phase1, Recruiting
Active & ResponsiveNew

A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck

for
Head and Neck Cancer
Location: Philadelphia PA
Sponsor: IBA Proton Therapy, Inc.

Sex: All

Age: 18+

Code: NCT07644585

Recruiting
Active & Responsive

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

for
Lymphedema of the Head and Neck
Location: Philadelphia PA, Nashville TN
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06125743

Recruiting
Active & Responsive

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

for
Squamous Cell Carcinoma of Head and Neck
Location: Mineola NY, New York NY, Little Rock AR,
Sponsor: University of Arkansas

Sex: All

Age: 18 - 70+

Code: NCT05952934

Phase2, Recruiting
Active & Responsive

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

for
Gastric Adenocarcinoma,
Location: New York NY, Durham NC, Winston-Salem NC, Chicago IL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05365581

Phase1, Recruiting
Active & Responsive

A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 50 - 70+

Code: NCT07324096

Recruiting
Active & Responsive

Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

for
Head and Neck Cancer Squamous Cell Carcinoma
Location: New Haven CT, Manhattan NY
Sponsor: VSPharmTech Co.,Ltd.

Sex: All

Age: 18+

Code: NCT06959082

Phase2, Recruiting
Active & Responsive

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

for
Head and Neck Cancer, Squamous Cell Carcinoma,
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT07209189

Phase2, Recruiting